|
Volumn 29, Issue SUPPL. 2, 2008, Pages 187-190
|
YB-1 as a potential target in cancer therapy;YB-1 als potenzielles ziel für die tumortherapie
|
Author keywords
Adenovirus; Gene therapy; Targeted therapy; Virotherapy; YB 1
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ESTROGEN RECEPTOR ALPHA;
GLYCOPROTEIN P;
MULTIDRUG RESISTANCE PROTEIN 1;
TRANSCRIPTION FACTOR;
TRASTUZUMAB;
VIRUS VECTOR;
Y BOX BINDING PROTEIN 1;
ADENOVIRUS 5;
BREAST CANCER;
CANCER RADIOTHERAPY;
CANCER THERAPY;
CELL NUCLEUS;
CELL PROLIFERATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYTOPLASM;
DRUG TARGETING;
GENE THERAPY;
GLIOBLASTOMA;
HUMAN;
HYPERTHERMIA;
INHIBITION KINETICS;
ONCOGENE NEU;
ONCOLYTIC VIROTHERAPY;
PROGNOSIS;
PROTEIN EXPRESSION;
PROTEIN LOCALIZATION;
PROTEIN TARGETING;
RADIATION;
VIRUS INFECTION;
VIRUS REPLICATION;
ADENOVIRUSES, HUMAN;
BREAST NEOPLASMS;
CELL DIVISION;
DNA-BINDING PROTEINS;
DRUG RESISTANCE, MULTIPLE;
DRUG RESISTANCE, NEOPLASM;
ESTROGEN RECEPTOR ALPHA;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENE TARGETING;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
HUMANS;
NEOPLASMS;
NUCLEAR PROTEINS;
P-GLYCOPROTEIN;
RECEPTOR, ERBB-2;
|
EID: 57449098679
PISSN: 01728113
EISSN: None
Source Type: Journal
DOI: 10.1007/s00292-008-1030-2 Document Type: Conference Paper |
Times cited : (14)
|
References (30)
|